Sidebar

  • Magazine
  • Events
  • Videos
  • Gallery
  • Blog
  • Gantry Home

Magazine menu

  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
The Power of Truth®
Tuesday, July 01, 2025
Tuesday, July 01, 2025
  • Home
  • News
    • China News
    • Religion
  • lifestyle
  • Tech
  • Financial
  • Military
  • Entertainment
  • Politics
  • Health
  • Sport
  • Environment
  • Opinion
  • Weather
  • Podcasts
  • Video
  • Ads
  1. You are here:  
  2. Health

Scientists develop novel antibody treatment for kidney cancer

Details
Staff logo
04 June 2024
Health
  • Previous Article Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050
  • Next Article Gonorrhoea cases reach record high in England
Scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in pre-clinical models as a potent, long-lasting treatment against ccRCC.
Scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in pre-clinical models as a potent, long-lasting treatment against ccRCC.

Read more https://www.sciencedaily.com/releases/2024/06/240604132003.htm

  • Previous Article Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050
  • Next Article Gonorrhoea cases reach record high in England

HUNGRY FOR TRUTH?  FEED THE NEED.

The Power of Truth®
  • Cookies Policy
  • Privacy Policy
  • Terms of Use
  • Contact
Copyright © 2025 Joomla!. All Rights Reserved. Powered by The Power of Truth® - Designed by JoomlArt.com. Bootstrap is a front-end framework of Twitter, Inc. Code licensed under Apache License v2.0. Font Awesome font licensed under SIL OFL 1.1.